Why have ovarian cancer mortality rates declined? Part III. Prospects for the future
Authors:
- 1 September 2015
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 138 (3) , 757-761
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- A model for estimating ovarian cancer risk: Application for preventive oophorectomyGynecologic Oncology, 2015
- Why have ovarian cancer mortality rates declined? Part I. IncidenceGynecologic Oncology, 2015
- Why have ovarian cancer mortality rates declined? Part II. Case-fatalityGynecologic Oncology, 2015
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014Journal of the National Comprehensive Cancer Network, 2014
- Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancerBritish Journal of Cancer, 2012
- Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeJAMA, 2011
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecologic Oncology, 2011
- Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health StudyObstetrics & Gynecology, 2009
- Recommendations for the Care of Individuals With an Inherited Predisposition to Lynch SyndromeJAMA, 2006
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003